Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings
AUM
$28.4B
1-Year Return
37.22%
This Quarter Return
+8.16%
1 Year Return
+37.22%
3 Year Return
+93.7%
5 Year Return
+199.54%
10 Year Return
+398.51%
AUM
$23.2B
AUM Growth
+$1.79B
(+8.3%)
Cap. Flow
+$478M
Cap. Flow
% of AUM
2.06%
Top 10 Holdings %
Top 10 Hldgs %
23.34%
Holding
1,754
New
402
Increased
609
Reduced
482
Closed
253
Top Buys
| 1 |
Manulife Financial
MFC
|
+$133M |
| 2 |
Canadian Imperial Bank of Commerce
CM
|
+$120M |
| 3 |
Scotiabank
BNS
|
+$89.9M |
| 4 |
CSX Corp
CSX
|
+$88.7M |
| 5 |
Cenovus Energy
CVE
|
+$83.6M |
Top Sells
| 1 |
Walt Disney
DIS
|
+$149M |
| 2 |
Merck
MRK
|
+$130M |
| 3 |
Toronto Dominion Bank
TD
|
+$106M |
| 4 |
Shopify
SHOP
|
+$80.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$79.2M |
Sector Composition
| 1 | Technology | 22.59% |
| 2 | Financials | 21.5% |
| 3 | Industrials | 12.21% |
| 4 | Energy | 10.78% |
| 5 | Consumer Discretionary | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Halliburton
HAL
$19.3B
| $252K | ﹤0.01% |
+6,400
| New | +$252K |
|
1327
Teledyne Technologies
TDY
$25.6B
| $251K | ﹤0.01% |
+585
| New | +$251K |
|
|
CTO
1328
CTO Realty Growth
CTO
$561M
| $251K | ﹤0.01% |
+14,807
| New | +$251K |
|
1329
HubSpot
HUBS
$25.8B
| $251K | ﹤0.01% |
+400
| New | +$251K |
|
|
EVBN
1330
DELISTED
Evans Bancorp Inc
EVBN
| $250K | ﹤0.01% |
+8,387
| New | +$250K |
|
1331
Hartford Financial Services
HIG
$36.9B
| $250K | ﹤0.01% |
+2,428
| New | +$250K |
|
1332
Kodiak Sciences
KOD
$513M
| $250K | ﹤0.01% |
+47,528
| New | +$250K |
|
1333
Dollar General
DG
$23.4B
| $250K | ﹤0.01% |
+1,600
| New | +$250K |
|
1334
CryoPort
CYRX
$480M
| $248K | ﹤0.01% |
14,038
-42,303
| -75% | -$749K |
|
1335
Baxter International
BAX
$12.3B
| $247K | ﹤0.01% |
5,785
-139,397
| -96% | -$5.96M |
|
1336
Datadog
DDOG
$48.5B
| $247K | ﹤0.01% |
2,000
-34,942
| -95% | -$4.32M |
|
1337
Devon Energy
DVN
$22.5B
| $247K | ﹤0.01% |
4,917
-62,348
| -93% | -$3.13M |
|
1338
Moderna
MRNA
$9.46B
| $245K | ﹤0.01% |
+2,300
| New | +$245K |
|
1339
FirstEnergy
FE
$25B
| $245K | ﹤0.01% |
6,338
-93,363
| -94% | -$3.61M |
|
1340
CenterPoint Energy
CNP
$24.7B
| $243K | ﹤0.01% |
+8,527
| New | +$243K |
|
1341
Equifax
EFX
$30.3B
| $243K | ﹤0.01% |
+908
| New | +$243K |
|
1342
UroGen Pharma
URGN
$884M
| $243K | ﹤0.01% |
16,188
-29,789
| -65% | -$447K |
|
1343
John Wiley & Sons Class A
WLY
$2.21B
| $243K | ﹤0.01% |
+6,365
| New | +$243K |
|
1344
Third Coast Bancshares
TCBX
$546M
| $242K | ﹤0.01% |
+12,071
| New | +$242K |
|
1345
Ichor Holdings
ICHR
$567M
| $241K | ﹤0.01% |
6,246
-11,325
| -64% | -$437K |
|
1346
Verisk Analytics
VRSK
$36.7B
| $240K | ﹤0.01% |
+1,019
| New | +$240K |
|
1347
ResMed
RMD
$39.6B
| $240K | ﹤0.01% |
1,211
-95,507
| -99% | -$18.9M |
|
1348
Xylem
XYL
$33.5B
| $239K | ﹤0.01% |
1,851
-10,472
| -85% | -$1.35M |
|
1349
Archer Daniels Midland
ADM
$29.5B
| $239K | ﹤0.01% |
3,800
-15,144
| -80% | -$951K |
|
1350
Fortive
FTV
$16.2B
| $238K | ﹤0.01% |
2,766
-43,931
| -94% | -$3.78M |
|